XGEN Venture

Venture Capital Italy ·Founded 2021

Overview

XGEN Venture is a Milan-based venture capital firm specializing in early-stage investments in the life sciences sector. Established in 2021 by the former Genextra team, the firm focuses on innovative therapeutics and medical devices, aiming to address high unmet medical needs. XGEN Venture launched its first fund, the XGEN Venture Life Science Fund, in December 2022, with a target of €200 million. The fund has successfully raised approximately €180 million, exceeding expectations and solidifying its position in the European life sciences investment landscape. The firm's investment strategy involves collaborating with exceptional scientists and entrepreneurs to translate advanced scientific research into patient solutions. XGEN Venture employs a strategic approach, leveraging its extensive network of scientific experts, seasoned entrepreneurs, and industry leaders to accelerate growth and innovation within its portfolio companies. The fund focuses on early-stage investments across biotechnology, medical devices, and diagnostics, with a commitment to responsible investing and integrating environmental, social, and governance (ESG) principles throughout its investment process. XGEN Venture has already begun deploying capital in several startups, including iOnctura B.V., a company pioneering therapies for neglected and hard-to-treat cancers. The firm plans approximately nine additional investments over the next two to three years to complete the fund’s portfolio. The team, with nearly two decades of experience, has a proven track record of building breakthrough life sciences startups in Italy and internationally, aiming to become one of the leading players in the European venture capital market.

Investment Focus

  • Early-stage companies
  • Innovative therapeutics
  • Medical devices
  • High unmet medical needs
  • European market focus

Portfolio Companies

iOnctura B.V.

Get the full list of 54,000+ investors

XGEN Venture and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about XGEN Venture

What sectors does XGEN Venture invest in?

XGEN Venture invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Italy. XGEN Venture is listed as a venture capital in the ConnectSafely investor database.

What stage does XGEN Venture invest at?

XGEN Venture backs companies at Early Stage, Series A, Series B and Growth.

Which regions does XGEN Venture invest in?

XGEN Venture invests across United States, United Kingdom, Germany, France, Italy and Denmark.

Who are the partners at XGEN Venture?

Team members listed for XGEN Venture include Federica Draghi (Founder & Managing Partner) and Khatereh Ahmadi (Venture Partner).

What companies has XGEN Venture invested in?

XGEN Venture's portfolio includes iOnctura B.V..

How do I contact XGEN Venture?

XGEN Venture's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database